Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0022 Transporter Info | ||||
| Gene Name | SLC15A2 | ||||
| Transporter Name | Peptide transporter 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Amoxicillin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 33613 | ||||
| Docking Score | -8.439 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H19N3O5S | ||||
| Molecular Weight | 365.4 | ||||
| Canonical SMILES |
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C
|
||||
| InChI |
InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1
|
||||
| InChIKey | LSQZJLSUYDQPKJ-NJBDSQKTSA-N | ||||
| Pharmaceutical Properties | Xlogp | -2 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Cefpodoxime Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 6335986 | ||||
| Docking Score | -8.393 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C15H17N5O6S2 | ||||
| Molecular Weight | 427.5 | ||||
| Canonical SMILES |
COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O
|
||||
| InChI |
InChI=1S/C15H17N5O6S2/c1-25-3-6-4-27-13-9(12(22)20(13)10(6)14(23)24)18-11(21)8(19-26-2)7-5-28-15(16)17-7/h5,9,13H,3-4H2,1-2H3,(H2,16,17)(H,18,21)(H,23,24)/b19-8-/t9-,13-/m1/s1
|
||||
| InChIKey | WYUSVOMTXWRGEK-HBWVYFAYSA-N | ||||
| Pharmaceutical Properties | Xlogp | -1.4 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 11 | ||
| Xenobiotic Name | Cephalexin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 27447 | ||||
| Docking Score | -8.333 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H17N3O4S | ||||
| Molecular Weight | 347.4 | ||||
| Canonical SMILES |
CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O
|
||||
| InChI |
InChI=1S/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1
|
||||
| InChIKey | ZAIPMKNFIOOWCQ-UEKVPHQBSA-N | ||||
| Pharmaceutical Properties | Xlogp | 0.6 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.